The CEO is the Accountable Authority under the Public Governance, Performance and Accountability Act 2013 (PGPA Act) and is responsible for the overall governance of the OTA.
Lucinda Barry AM has been the Chief Executive Officer of the OTA since 2017. She is responsible for leading the day-to-day operations of the OTA and is a member of the Board.
Lucinda has extensive experience in health care, both clinical and policy. She has held senior leadership roles within government, the public service and in health service management and delivery.
Lucinda represents the Australian Government on several national and international committees, including: The Australian COVID-19 Donation and Transplantation Rapid Response Taskforce; National Indigenous Kidney Transplantation Taskforce; Commonwealth 'Tribute to Life' International Advisory Panel; and the International COVID-19 Donation and Transplantation meeting. She is also a member of Australia’s Jurisdictional Organ Donation, Retrieval and Transplantation Steering Committee and the Jurisdictional Eye and Tissue Steering Committee.
Lucinda is the Australian Government’s national media spokesperson on organ and tissue donation and is an invited speaker at both national and international conferences.
